Current treatment options for familial adult myoclonus epilepsy
Epilepsia · 2023
DOI: 10.1111/epi.17590 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2023. Verfasst von Antonietta Coppola und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Reproductive Sciences, and Odontostomatology, Federico II University of Naples, Naples, Italy. Hauptthemen laut MEDLINE: Myoclonus, Epilepsy, Epilepsies, Myoclonic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Università degli Studi di Napoli Federico II.
Abstract (Originalsprache)
Familial adult myoclonus epilepsy (FAME) is a genetic condition characterized by the occurrence of cortical tremor, myoclonus, and epilepsy. To date, there is neither a curative nor a preventive treatment for FAME. Clinical management is essentially symptomatic and based on antiseizure medications (ASMs). The choice of the correct therapeutic option is limited to ASMs that have both an antiseizure and an antimyoclonic effect, such as valproate, levetiracetam, benzodiazepines, and perampanel. However, these medications control seizures well while having a limited effect on myoclonus and cortical tremor. In addition, many ASMs, including sodium channel blockers and gabapentin, are contraindicated in this condition. The ideal therapeutic option would be a precision treatment able to revert the genetic defect underlying it. Nevertheless, this does not seem to be an option that will be available soon.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Reproductive Sciences, and Odontostomatology, Federico II University of Naples, Naples, Italy.
- IRCCS Istituto delle Scienze Neurologiche di Bologna, full member of the European Reference Network EpiCARE Bologna, Bologna, Italy.
- Clinical Institute of Neurosciences, Hospital Clinic of Barcelona, Barcelona, Spain.
- Epilepsy Unit, Hospital Clinic of Barcelona, Barcelona, Spain.
- Biomedical Research Institute August Pi i Sunyer, Hospital Clinic of Barcelona, Barcelona, Spain.
- Epilepsy Unit "Françis Rohmer," French Centre de référence des Épilepsies Rares (CréER), Federation Hospitalo Universitaire, Neurology Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
ORCID-Profile: Antonietta Coppola, Raffaele Dubbioso, Laura Licchetta, Edouard Hirsch
Förderung
- Università degli Studi di Napoli Federico II
Zitieren
APA
Coppola, A., Dubbioso, R., Cuccurullo, C., Licchetta, L., Carreno, M., Hirsch, E., & Bilo, L. (2023). Current treatment options for familial adult myoclonus epilepsy. Epilepsia. https://doi.org/10.1111/epi.17590
Vancouver
Coppola A, Dubbioso R, Cuccurullo C, Licchetta L, Carreno M, Hirsch E, et al. Current treatment options for familial adult myoclonus epilepsy. Epilepsia. 2023. doi:10.1111/epi.17590
BibTeX
@article{Coppola2023,
author = {Coppola, Antonietta and Dubbioso, Raffaele and Cuccurullo, Claudia and Licchetta, Laura and Carreno, Mar and Hirsch, Edouard and Bilo, Leonilda},
title = {Current treatment options for familial adult myoclonus epilepsy},
journal = {Epilepsia},
year = {2023},
doi = {10.1111/epi.17590}
}
EUVIMED